Skip to main content
Erschienen in: Annals of Surgical Oncology 4/2014

01.04.2014 | Breast Oncology

Surgeon-Performed Touch Preparation of Breast Core Needle Biopsies May Provide Accurate Same-Day Diagnosis and Expedite Treatment Planning

verfasst von: Pranjali V. Gadgil, MBBS, Soheila Korourian, MD, Sharp Malak, MD, MPH, Daniela Ochoa, MD, Riley Lipschitz, BS, Ronda Henry-Tillman, MD, V. Suzanne Klimberg, MD

Erschienen in: Annals of Surgical Oncology | Ausgabe 4/2014

Einloggen, um Zugang zu erhalten

Abstract

Background

We aimed to determine the accuracy of surgeon-performed touch-preparation cytology (TPC) of breast core-needle biopsies (CNB) and the ability to use TPC results to initiate treatment planning at the same patient visit.

Methods

A single-institution retrospective review of TPC results of ultrasound-guided breast CNB was performed. All TPC slides were prepared by surgeons performing the biopsy and interpreted by the pathologist. TPC results were reported as positive/suspicious, atypical, negative/benign, or deferred; these were compared with final pathology of cores to calculate accuracy. Treatment planning was noted as having taken place if the patient had requisition of advanced imaging, referrals, or surgical planning undertaken during the same visit.

Results

Four hundred forty-seven CNB specimens with corresponding TPC were evaluated from 434 patient visits, and 203 samples (45.4 %) were malignant on final pathology. When the deferred, atypical, and benign results were considered negative and positive/suspicious results were considered positive, sensitivity and specificity were 83.7 % (77.9–88.5 %) and 98.4 % (95.9–99.6 %), respectively; positive and negative predictive values were 97.7 % (94.2–99.4 %) and 87.9 % (83.4–91.5 %), respectively. In practice, patients with atypical or deferred results were asked to await final pathology. An accurate same-day diagnosis (TPC positive/suspicious) was hence feasible in 83.7 % (170 of 203) of malignant and 79.5 % (194 of 244) of benign cases (TPC negative). Of patients who had a same-day diagnosis of a new malignancy, 77.3 % had treatment planning initiated at the same visit.

Conclusions

Surgeon-performed TPC of breast CNB is an accurate method of same-day diagnosis that allows treatment planning to be initiated at the same visit and may serve to expedite patient care.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Devaraj S, Iqbal M, Donnelly J, Corder, AP. Axillary ultrasound in invasive breast cancer: experience of our surgeons. Breast J. 2011;17:191–195.PubMedCrossRef Devaraj S, Iqbal M, Donnelly J, Corder, AP. Axillary ultrasound in invasive breast cancer: experience of our surgeons. Breast J. 2011;17:191–195.PubMedCrossRef
2.
Zurück zum Zitat Law MT, Bennett IC. Structured ultrasonography workshop for breast surgeons: is it an effective training tool? World J Surg. 2010;34:549–554.PubMedCrossRef Law MT, Bennett IC. Structured ultrasonography workshop for breast surgeons: is it an effective training tool? World J Surg. 2010;34:549–554.PubMedCrossRef
3.
Zurück zum Zitat Layeequr Rahman R, Crawford S, Hall T, et al. Surgical-office-based versus radiology-referral-based breast ultrasonography: a comparison of efficiency, cost, and patient satisfaction. J Am Coll Surg. 2008;207:763–766.PubMedCrossRef Layeequr Rahman R, Crawford S, Hall T, et al. Surgical-office-based versus radiology-referral-based breast ultrasonography: a comparison of efficiency, cost, and patient satisfaction. J Am Coll Surg. 2008;207:763–766.PubMedCrossRef
4.
Zurück zum Zitat Holmes DR, Silverstein MJ. A minimally invasive breast biopsy clinic: an innovative way to teach breast fellows how to perform breast ultrasound and ultrasound-guided breast procedures. Am J Surg. 2006;192:439–443.PubMedCrossRef Holmes DR, Silverstein MJ. A minimally invasive breast biopsy clinic: an innovative way to teach breast fellows how to perform breast ultrasound and ultrasound-guided breast procedures. Am J Surg. 2006;192:439–443.PubMedCrossRef
5.
Zurück zum Zitat Rakha EA, Ellis IO. An overview of assessment of prognostic and predictive factors in breast cancer needle core biopsy specimens. J Clin Pathol. 2007;60:1300–1306.PubMedCentralPubMedCrossRef Rakha EA, Ellis IO. An overview of assessment of prognostic and predictive factors in breast cancer needle core biopsy specimens. J Clin Pathol. 2007;60:1300–1306.PubMedCentralPubMedCrossRef
6.
Zurück zum Zitat Willems SM, van Deurzen CH, van Diest PJ. Diagnosis of breast lesions: fine-needle aspiration cytology or core needle biopsy? A review. J Clin Pathol. 2012;65:287–292.CrossRef Willems SM, van Deurzen CH, van Diest PJ. Diagnosis of breast lesions: fine-needle aspiration cytology or core needle biopsy? A review. J Clin Pathol. 2012;65:287–292.CrossRef
7.
Zurück zum Zitat Garg S, Mohan H, Bal A, Attri AK, & Kochhar S, et al. A comparative analysis of core needle biopsy and fine-needle aspiration cytology in the evaluation of palpable and mammographically detected suspicious breast lesions. Diagn Cytopathol. 2007; 35:681–689.PubMedCrossRef Garg S, Mohan H, Bal A, Attri AK, & Kochhar S, et al. A comparative analysis of core needle biopsy and fine-needle aspiration cytology in the evaluation of palpable and mammographically detected suspicious breast lesions. Diagn Cytopathol. 2007; 35:681–689.PubMedCrossRef
8.
Zurück zum Zitat Smith MJ, Heffron CC, Rothwell JR, Loftus BM, Jeffers M, & Geraghty JG, et al. Fine needle aspiration cytology in symptomatic breast lesions: still an important diagnostic modality? Breast J. 2012;18:103–110.PubMedCrossRef Smith MJ, Heffron CC, Rothwell JR, Loftus BM, Jeffers M, & Geraghty JG, et al. Fine needle aspiration cytology in symptomatic breast lesions: still an important diagnostic modality? Breast J. 2012;18:103–110.PubMedCrossRef
9.
Zurück zum Zitat Maeda S, Hosone M, Katayama H, Isobe H, Yanagida Y, Egami K, et al. Rapid diagnosis at the outpatient clinic for breast tumors by fine needle aspiration cytology: the utility. Nihon Ika Daigaku Zasshi. 1998;65:416–420.PubMed Maeda S, Hosone M, Katayama H, Isobe H, Yanagida Y, Egami K, et al. Rapid diagnosis at the outpatient clinic for breast tumors by fine needle aspiration cytology: the utility. Nihon Ika Daigaku Zasshi. 1998;65:416–420.PubMed
10.
Zurück zum Zitat Dayal S, Murray J, Wilson K, Lannigan A, et al. Imprint cytology from core biopsies increases the sensitivity of fine needle aspiration (FNA) in breast cancer patients. Magy Seb. 2011;64:59–62.PubMedCrossRef Dayal S, Murray J, Wilson K, Lannigan A, et al. Imprint cytology from core biopsies increases the sensitivity of fine needle aspiration (FNA) in breast cancer patients. Magy Seb. 2011;64:59–62.PubMedCrossRef
11.
Zurück zum Zitat Kass R, Henry-Tillman RS, Nurko J, Korourian S, Mancino AT, Colvert M, et al. Touch preparation of breast core needle specimens is a new method for same-day diagnosis. Am J Surg. 2003;186:737–741.PubMedCrossRef Kass R, Henry-Tillman RS, Nurko J, Korourian S, Mancino AT, Colvert M, et al. Touch preparation of breast core needle specimens is a new method for same-day diagnosis. Am J Surg. 2003;186:737–741.PubMedCrossRef
12.
Zurück zum Zitat Galen RS, Gambino SR. Beyond normality: the predictive value and efficiency of medical diagnoses. New York: Wiley; 1975. Galen RS, Gambino SR. Beyond normality: the predictive value and efficiency of medical diagnoses. New York: Wiley; 1975.
13.
Zurück zum Zitat Dey P, Bundred N, Gibbs A, Hopwood P, Baildam A, Boggis C, et al. Costs and benefits of a one stop clinic compared with a dedicated breast clinic: randomised controlled trial. BMJ. 2002;324:507.PubMedCentralPubMedCrossRef Dey P, Bundred N, Gibbs A, Hopwood P, Baildam A, Boggis C, et al. Costs and benefits of a one stop clinic compared with a dedicated breast clinic: randomised controlled trial. BMJ. 2002;324:507.PubMedCentralPubMedCrossRef
14.
Zurück zum Zitat Kulkarni D, Irvine T, Reyes RJ. The use of core biopsy imprint cytology in the ‘one-stop’ breast clinic. Eur J Surg Oncol. 2009;35:1037–1040.PubMedCrossRef Kulkarni D, Irvine T, Reyes RJ. The use of core biopsy imprint cytology in the ‘one-stop’ breast clinic. Eur J Surg Oncol. 2009;35:1037–1040.PubMedCrossRef
15.
Zurück zum Zitat Carmichael AR, Berresford A, Sami A, Boparai R. Imprint cytology of needle core-biopsy specimens of breast lesion: is it best of both worlds? Breast. 2004;13:232–234.PubMedCrossRef Carmichael AR, Berresford A, Sami A, Boparai R. Imprint cytology of needle core-biopsy specimens of breast lesion: is it best of both worlds? Breast. 2004;13:232–234.PubMedCrossRef
16.
Zurück zum Zitat Klevesath MB, Godwin RJ, Bannon R, Munthali L, & Coveney E. Touch imprint cytology of core needle biopsy specimens: a useful method for immediate reporting of symptomatic breast lesions. Eur J Surg Oncol. 2005;31:490–494.PubMedCrossRef Klevesath MB, Godwin RJ, Bannon R, Munthali L, & Coveney E. Touch imprint cytology of core needle biopsy specimens: a useful method for immediate reporting of symptomatic breast lesions. Eur J Surg Oncol. 2005;31:490–494.PubMedCrossRef
17.
Zurück zum Zitat Masood S, Feng D, Tutuncuoglu O, Fischer G, Bakhshandeh M, Bertholf RL, et al. Diagnostic value of imprint cytology during image-guided core biopsy in improving breast health care. Ann Clin Lab Sci. 2011;41:8–13.PubMed Masood S, Feng D, Tutuncuoglu O, Fischer G, Bakhshandeh M, Bertholf RL, et al. Diagnostic value of imprint cytology during image-guided core biopsy in improving breast health care. Ann Clin Lab Sci. 2011;41:8–13.PubMed
18.
Zurück zum Zitat Qureshi NA, Beresford A, Sami S, Boparai R, Gosh S, & Carmichael AR, et al. Imprint cytology of needle core-biopsy specimens of breast lesions: is it a useful adjunct to rapid assessment breast clinics? Breast. 2007;16:81–85.PubMedCrossRef Qureshi NA, Beresford A, Sami S, Boparai R, Gosh S, & Carmichael AR, et al. Imprint cytology of needle core-biopsy specimens of breast lesions: is it a useful adjunct to rapid assessment breast clinics? Breast. 2007;16:81–85.PubMedCrossRef
19.
Zurück zum Zitat Farshid G, Pieterse S. Core imprint cytology of screen-detected breast lesions is predictive of the histologic results. Cancer. 2006;108:150–156.PubMedCrossRef Farshid G, Pieterse S. Core imprint cytology of screen-detected breast lesions is predictive of the histologic results. Cancer. 2006;108:150–156.PubMedCrossRef
20.
Zurück zum Zitat Jones L, Lott MF, Calder CJ, & Kutt E. Imprint cytology from ultrasound-guided core biopsies: accurate and immediate diagnosis in a one-stop breast clinic. Clin Radiol. 2004;59:903–908.PubMedCrossRef Jones L, Lott MF, Calder CJ, & Kutt E. Imprint cytology from ultrasound-guided core biopsies: accurate and immediate diagnosis in a one-stop breast clinic. Clin Radiol. 2004;59:903–908.PubMedCrossRef
22.
Zurück zum Zitat Eastman A, Tammaro Y, Moldrem A, Andrews V, Huth J, Euhus D, et al. Outcomes of delays in time to treatment in triple negative breast cancer. Ann Surg Oncol. 2013; 20: 1880–1885.PubMedCrossRef Eastman A, Tammaro Y, Moldrem A, Andrews V, Huth J, Euhus D, et al. Outcomes of delays in time to treatment in triple negative breast cancer. Ann Surg Oncol. 2013; 20: 1880–1885.PubMedCrossRef
23.
Zurück zum Zitat Mujar M, Dahlui M, Yip CH, & Taib NA, et al. Delays in time to primary treatment after a diagnosis of breast cancer: does it impact survival? Prev Med. 2013; 56: 222–224.PubMedCrossRef Mujar M, Dahlui M, Yip CH, & Taib NA, et al. Delays in time to primary treatment after a diagnosis of breast cancer: does it impact survival? Prev Med. 2013; 56: 222–224.PubMedCrossRef
24.
Zurück zum Zitat Brazda A, Estroff J, Euhus D, Huth J, Andrews V, Moldrem A, et al. Delays in time to treatment and survival impact in breast cancer. Ann Surg Oncol. 2010; 17(Suppl. 3): 291–296.PubMedCrossRef Brazda A, Estroff J, Euhus D, Huth J, Andrews V, Moldrem A, et al. Delays in time to treatment and survival impact in breast cancer. Ann Surg Oncol. 2010; 17(Suppl. 3): 291–296.PubMedCrossRef
25.
Zurück zum Zitat Sainsbury JR, Johnston C, Haward B. Effect on survival of delays in referral of patients with breast-cancer symptoms: a retrospective analysis. Lancet. 1999;353:1132–1135.PubMedCrossRef Sainsbury JR, Johnston C, Haward B. Effect on survival of delays in referral of patients with breast-cancer symptoms: a retrospective analysis. Lancet. 1999;353:1132–1135.PubMedCrossRef
Metadaten
Titel
Surgeon-Performed Touch Preparation of Breast Core Needle Biopsies May Provide Accurate Same-Day Diagnosis and Expedite Treatment Planning
verfasst von
Pranjali V. Gadgil, MBBS
Soheila Korourian, MD
Sharp Malak, MD, MPH
Daniela Ochoa, MD
Riley Lipschitz, BS
Ronda Henry-Tillman, MD
V. Suzanne Klimberg, MD
Publikationsdatum
01.04.2014
Verlag
Springer US
Erschienen in
Annals of Surgical Oncology / Ausgabe 4/2014
Print ISSN: 1068-9265
Elektronische ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-013-3440-5

Weitere Artikel der Ausgabe 4/2014

Annals of Surgical Oncology 4/2014 Zur Ausgabe

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren. 

Wie sieht der OP der Zukunft aus?

04.05.2024 DCK 2024 Kongressbericht

Der OP in der Zukunft wird mit weniger Personal auskommen – nicht, weil die Technik das medizinische Fachpersonal verdrängt, sondern weil der Personalmangel es nötig macht.

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Recycling im OP – möglich, aber teuer

02.05.2024 DCK 2024 Kongressbericht

Auch wenn sich Krankenhäuser nachhaltig und grün geben – sie tragen aktuell erheblich zu den CO2-Emissionen bei und produzieren jede Menge Müll. Ein Pilotprojekt aus Bonn zeigt, dass viele Op.-Abfälle wiederverwertet werden können.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.